(-0.41%) 5 460.48 points
(-0.12%) 39 119 points
(-0.71%) 17 733 points
(-0.34%) $81.46
(-3.13%) $2.60
(0.01%) $2 336.90
(0.61%) $29.44
(0.28%) $1 009.00
(-0.06%) $0.933
(0.45%) $10.68
(-0.05%) $0.791
(0.86%) $85.73
Live Chart Being Loaded With Signals
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores...
Stats | |
---|---|
Šios dienos apimtis | 1.97M |
Vidutinė apimtis | 1.02M |
Rinkos kapitalizacija | 49.33M |
EPS | $0 ( Q3 | 2023-11-16 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-2.41 (Sector) 42.63 (Industry) 0 |
ATR14 | $0.144 (10.99%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-29 | Gulyas John | Buy | 3 000 | Common stock |
2023-12-28 | Gulyas John | Buy | 2 500 | Common stock |
2023-12-28 | Gulyas John | Buy | 2 500 | Common stock |
2023-09-01 | Boon Jarrett Adam | Buy | 0 | Common Stock |
2023-08-31 | Gulyas John | Buy | 1 666 666 | Common stock |
INSIDER POWER |
---|
99.38 |
Last 89 transactions |
Buy: 11 303 898 | Sell: 784 416 |
Tūris Koreliacija
Jupiter Wellness, Inc. Koreliacija
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Jupiter Wellness, Inc. Koreliacija - Valiuta/Žaliavos
Jupiter Wellness, Inc. Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $6.20M |
Bruto pelnas: | $1.03M (16.56 %) |
EPS: | $-0.800 |
FY | 2022 |
Pajamos: | $6.20M |
Bruto pelnas: | $1.03M (16.56 %) |
EPS: | $-0.800 |
FY | 2021 |
Pajamos: | $2.88M |
Bruto pelnas: | $535 485 (18.62 %) |
EPS: | $-3.84 |
FY | 2020 |
Pajamos: | $1.07M |
Bruto pelnas: | $441 095 (41.39 %) |
EPS: | $-0.860 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Jupiter Wellness, Inc.
Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.